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Virus replicationTo investigate novel NS1-interacting proteins, we conducted a yeast two-hybrid analysis, followed by co-
immunoprecipitation assays. We identiﬁed heterogeneous nuclear ribonucleoprotein F (hnRNP-F) as a
cellular protein interacting with NS1 during inﬂuenza A virus infection. Co-precipitation assays suggest
that interaction between hnRNP-F and NS1 is a common and direct event among human or avian inﬂuenza
viruses. NS1 and hnRNP-F co-localize in the nucleus of host cells, and the RNA-binding domain of NS1
directly interacts with the GY-rich region of hnRNP-F determined by GST pull-down assays with truncated
proteins. Importantly, hnRNP-F expression levels in host cells indicate regulatory role on virus replication.
hnRNP-F depletion by small interfering RNA (siRNA) shows 10- to 100-fold increases in virus titers
corresponding to enhanced viral RNA polymerase activity. Our results delineate novel mechanism of action
by which NS1 accelerates inﬂuenza virus replication by modulating normal cellular mRNA processes
through direct interaction with cellular hnRNP-F protein.
© 2009 Elsevier Inc. All rights reserved.
CTA
Introduction
The inﬂuenza A virus causes highly infectious respiratory disease
in a wide variety of species, including human, birds, swine, horses,
minks, seals, whales, and most recently from cats, tigers, and dogs
(Webster et al., 1992; Songserm et al., 2006a, 2006b; Garaigorta
and Ortin, 2007). Inﬂuenza A viruses are members of the family
Orthomyxoviridae with a genome consisting of eight single-stranded
RNA segments of negative polarity, and these RNA segments encode
11 viral proteins (Burgui et al., 2003).
The non-structural (NS) gene of inﬂuenza A virus encodes two
functional proteins: the NS protein 1 (NS1) and the nuclear export
protein (NEP; also called NS2) (Kawaoka et al., 1998; Paragas et al.,
2001). NS1 is encoded by a co-linear mRNA consisting of 234–237
amino acids, depending on the virus strain, and is localized in the
nucleus without the existence of other viral proteins (Kawaoka et al.,
1998). NEP mediates the export of viral ribonucleoproteins (vRNPs)
(Paragas et al., 2001). NS1 is a unique non-structural protein that
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ll rights reserved.contains two functional domains, the RNA-binding domain and the
effector domain (Murayama et al., 2007), which is translated from
the eighth segment of the viral genome and acts as a crucial
regulatory factor (Krug et al., 2003; Kash et al., 2006; Hale et al.,
2008a). A symmetrical homodimeric RNA-binding domain is formed
by the N-terminal 73 amino acids of NS1 (Donelan et al., 2003; Yin
et al., 2007) which is involved in inhibition of both interferon (IFN)
induction (Min and Krug, 2006) and the antiviral effects of IFN
(Noah et al., 2003). The C-terminal amino acids comprising the
effector domain (residues 74–230) bind numerous cellular proteins
to execute the following functions: (i) elevation of viral mRNA
translation (Enami et al., 1994; De la et al., 1995; Aragon et al.,
2000), (ii) suppression of cellular mRNA processing (Fortes et al.,
1994; Lu et al., 1994), (iii) inhibition of dsRNA-activated protein
kinase (PKR) (Hale et al., 2006), and (iv) activation of phosphoinosi-
tide 3-kinase (PI3K) signaling (Shimizu et al., 1999). Thus, the
effector domain of NS1 interacts with many cellular proteins during
translation and post-transcriptional processing of RNA (Krug et al.,
2003; Kash et al., 2006; Hale et al., 2008a). NS1 binds with the
cleavage and polyadenylation speciﬁcity factor 4 (CPSF4), suppresses
the cleavage of mRNA at the poly (A)-binding site, and blocks
cellular protein synthesis (Nemeroff et al., 1998).
When synthesized during transcription, poly (A)-containing RNA
polymerase II (pol II) transcripts associate with a family of nuclear
proteins, forming complexes with heterogeneous nuclear ribonucleo-
proteins (hnRNPs) to be processed into mature transcripts (Dreyfuss
90 J.H. Lee et al. / Virology 397 (2010) 89–99et al., 1993; Matunis et al., 1994). hnRNPs show a sequence-speciﬁc
RNA-binding activity, and the majority of them are discovered solely
in the nucleus, while others are known to shuttle between the
cytoplasm and nucleus (Krecic and Swanson, 1999; Honore et al.,
2004). These diverse family of highly abundant nuclear proteins
includes 20 proteins, designated alphabetically as hnRNP-A to -U
(Dreyfuss et al., 1993; Venables et al., 2008) which contain RNA
recognition motifs (RRM) and supplementary domains made up of
diverse amino acids (Biamonti and Riva, 1994). Their proposed
function is primarily for RNA binding as well as annealing of RNA,
protein–protein interactions, nuclear localization, RNA splicing
(Dreyfuss et al., 1993), mRNA trafﬁcking, telomere length control,
mRNA stability, transcription, and polyadenylation (Honore et al.,
2004). Recently, studies have demonstrated that many viruses
interact with various members of the hnRNP family. hnRNP A1 not
only functions as an internal ribosome entry site (IRES) trans-actingFig. 1. Interaction of inﬂuenza A virus NS1 with hnRNP-F. (a, b) Reciprocal Co-IP assay of P
transfected with Myc-PR8-NS1 and Flag-hnRNP-F expression vectors were immunoprecipit
co-precipitated with NS1 and hnRNP-F were analyzed by Western blotting with anti-Flag an
PR8-NS1 and Flag-hnRNP-F were co-transfected into 293T cells; cell lysates were prepared
Immunoprecipitates were analyzed by immunoblotting with anti-c-Myc and anti-Flag mon
lysates from 293T cells transiently transfected with empty vector (Vec) or Flag-hnRNP-F
(10 μg/ml), and then immunoprecipitated with anti-c-Myc monoclonal antibody. The immu
(e) Co-precipitation of hnRNP-F and NS1 by individually expressed and puriﬁed proteins
expressed in HEK 293T cells. Proteins were puriﬁed and used for co-precipitation as describ
bead-bound Myc-tagged NS1 or NP, the mixtures were incubated, the beads were washed
rabbit polyclonal antibody. “+” indicates loading of puriﬁed GST-hnRNP-F protein as positi
co-precipitated with NS1.
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Afactor that binds speciﬁcally to the 5′ untranslated region (UTR) of
enterovirus 71 (EV71) and regulates IRES-dependent translation, but
also facilitates translation of Sindbis virus (SV) by binding to its 5′UTR
(Lin et al., 2009). hnRNP L and D play important roles in translation
and proliferation of hepatitis viruses by interacting with their IRES
(Paek et al., 2008; Hwang et al., 2009; Sikora et al., 2009). In addition,
some hnRNPs may inﬂuence the life cycle and viral replication of
vesicular stomatitis and dengue viruses by favoring their survival in
the host cells (Gupta et al., 1998; Noisakran et al., 2008). However,
overexpression of certain hnRNPs in retrovirus-infected cells, particu-
larly human immunodeﬁciency virus type 1 (HIV-1), inhibits viral
translation and causes a dramatic decrease in virion production
(Bolinger and Boris-Lawrie, 2009; Jablonski and Caputi, 2009).
Particularly, hnRNPM and H1 have been initially identiﬁed as binding
partners of the polymerase-associated proteins of the inﬂuenza virus
with roles yet to be determined (Jorba et al., 2008).R8-NS1 and hnRNP-F in HEK 293T cells. Whole cell lysates from 293T cells transiently
ated with anti-c-Myc, anti-Flag to precipitate NS1 and hnRNP-F, respectively. Proteins
d anti-Myc, respectively. (c) NS1 interacts with hnRNP-F but not with mouse IgG. Myc-
30 h post transfection and precipitated with monoclonal NS1 or mouse IgG antibody.
oclonal antibodies. (d) RNA-independent interaction of hnRNP-F and NS1. Whole cell
and Myc-PR8-NS1 expression vectors were pre-incubated with or without RNase A
noprecipitates were analyzed by immunoblotting with anti-Flag monoclonal antibody.
. GST-tagged hnRNP-F was expressed in bacteria, and Myc-tagged NS1 and NP were
ed in Materials and methods. GST-tagged hnRNP-F was mixed with bead-immobilized/
and boiled, and the samples were analyzed by Western blotting with anti-hnRNP-F
ve control. “GST” indicates negative control. “GST-F” indicates GST-hnRNP-F protein as
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Fig. 2. Co-immunoprecipitation of hnRNP-F and other NS1 sub-types. (a) Co-
immunoprecipitation of hnRNP-F with W150-NS1. 293T cells were co-transfected
with Myc-W150-NS1 and Flag-hnRNP-F expression vectors. (b) Co-immunoprecipita-
tion of hnRNP-F with WSN-NS1. 293T cells were co-transfected with Myc-WSN-NS1
and Flag-hnRNP-F expression vectors. Whole cell extracts were immunoprecipitated
with anti-Flag monoclonal antibody. Immunoprecipitates were analyzed by immuno-
blotting with anti-c-Myc monoclonal antibody. Expression levels of hnRNP-F and
W150-NS1 (a) and WSN-NS1 (b) in the transfected cells were determined with anti-
Flag l and anti-c-Myc monoclonal antibodies, respectively.
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AIn the present study, we identiﬁed cellular proteins that
interact with NS1 using both yeast two-hybrid screening and co-
immunoprecipitation. We focused on the interaction of heteroge-
neous nuclear ribonucleoprotein-F (hnRNP-F) and NS1 to deter-
mine this biological signiﬁcance. Our ﬁndings suggest that both
proteins directly interact with each other through the GY-rich
region of hnRNP-F and the RNA-binding domain of NS1, and
expression levels of hnRNP-F in the host cells correlate with the
replication kinetics of inﬂuenza virus.
Results
hnRNP-F interacts with the NS1 protein of inﬂuenza A virus
To identify cellular proteins interacting with the NS1 protein of
inﬂuenza A virus, we initially conducted a yeast two-hybrid assay and
obtained a number of potential positive clones (data not shown). The
present study is focused on one of the NS1-binding cellular proteins,
hnRNP-F. To conﬁrm whether NS1 and hnRNP-F directly interact in
293T cells, PR8-NS1 and hnRNP-F were cloned into pcDNA3.1-Myc-
His (Myc-PR8-NS1) and pFLAG-CMV (Flag-hnRNP-F) vectors, respec-
tively. Whole cell lysates were prepared at 30 h post transfection and
the potential interaction between hnRNP-F and NS1 was determined
by reciprocal precipitation of cell lysates with an anti-Flag and anti-c-
Myc monoclonal antibody in conjunction with protein-G sepharose.
NS1 protein was co-precipitated with hnRNP-F when Flag-hnRNP-F
was precipitated with an anti-Flag monoclonal antibody (Fig. 1a).
Conversely, hnRNP-F was co-precipitated with NS1 when Myc-PR8-
NS1 was also precipitated with an anti-c-Myc monoclonal antibody
(Fig. 1b). A monoclonal antibody recognizing inﬂuenza NS1 also co-
precipitated hnRNP-F and NS1 from cell lysates but not mouse IgG
(Fig. 1c). Furthermore, co-precipitation with other tagged viral pro-
tein (Myc-PR8-NP) or randomly selected members of the hnRNP
family of proteins (Flag-hnRNP-A, C, H1, and K) did not pull-down
hnRNP-F or NS1, respectively (unpublished data). These data suggest
that the physical interaction observed between viral NS1 and host cell
hnRNP-F proteins could be speciﬁc only for the two proteins.
Since both NS1 and hnRNP-F are RNA-binding proteins, it is possible
that the NS1–hnRNP-F binding might be mediated through RNA
interactions. To rule out a plausible RNA-mediated interaction of NS1
and hnRNP-F, immunoprecipitation was performed after treatment of
the lysates with RNase A (10 μg/ml). As shown in Fig. 1d, hnRNP-F was
able to immunoprecipitate with NS1 in the RNase-A-treated lysates,
although the interaction intensity was relatively diminished compared
to that observed from the lysates that were not treated with RNase A.
To validate the direct interaction of NS1 and hnRNP-F, individually
expressed and puriﬁed proteins were examined by an in vitro binding
assay. GST-tagged hnRNP-F was expressed in bacteria and puriﬁed
using glutathione-sepharose 4B beads. Myc-tagged NS1, meanwhile,
was expressed in 293T cells and puriﬁed by immunoprecipitation
with anti–c-Myc monoclonal antibody. As shown in Fig. 1e, Myc-
tagged NS1 was able to pull down bacterially expressed GST-tagged
hnRNP-F. In contrast, Myc-tagged NP (control viral protein) did not
pull down hnRNP-F (Fig. 1e), which is consistent with the co-
precipitation results obtained in transient-transfection assays. Taken
together, this ﬁnding provides evidence supporting a direct interac-
tion between inﬂuenza virus NS1 and cellular hnRNP-F protein.
hnRNP-F interacts with various NS1
To determine that the interaction of NS1 and hnRNP-F is a common
phenomenon in different strain-derived NS1 proteins, we performed
co-immunoprecipitation assays with the NS1 proteins derived from
A/WSN/1933 (H1N1) and A/EM/Korea/W150/2006 (H5N1)
viruses, both of which contain different amino acid sequences in
their NS1 proteins, as compared to that of A/Puerto Rico/8/1934
ET(H1N1). We found that both NS1 variants of A/WSN/1933(H1N1)
and A/EM/Korea/W150/2006 (H5N1) viruses co-precipitated with
Flag-hnRNP-F (Fig. 2), indicating that the interaction between NS1
and hnRNP-F is likely a general phenomenon and might be
applicable to other inﬂuenza virus NS1 proteins, unlike the noted
interaction between NS1 and cellular CPSF4 (Nemeroff et al., 1998).
hnRNP-F co-localizes with NS1 protein in transiently transfected and
virus-infected cells
Although NS1 is known to localize predominantly to the nucleus
in virus-infected cells, a signiﬁcant proportion of this protein can also
be found in the cytoplasm (Greenspan et al., 1988; Newby et al.,
2007). On the other hand, hnRNP-F proteins were found to be
concentrated in numerous discrete regions throughout the nucleo-
plasm, and some protein was detected in the cytoplasm (Matunis
et al., 1994). To obtain additional evidence on the interaction
between inﬂuenza virus NS1 and cellular hnRNP-F, the sub-cellular
distribution of the two interacting proteins was determined by
double immunoﬂuorescence staining and confocal microscopy. After
co-transfection with Myc-PR8-NS1 and Flag-hnRNP-F plasmids, 293T
cells were ﬁxed at two time points (12 and 24 h post transfection)
and incubated with both anti-c-Myc monoclonal and anti-hnRNP-F
rabbit polyclonal antibodies. Immunoﬂuorescence showed that
hnRNP-F is highly abundant throughout the nucleoplasm with a
small amount of punctate cytoplasmic staining, consistent with pre-
vious ﬁndings (Matunis et al., 1994). NS1 showed a similar dis-
tribution pattern in the nucleus and was co-localized with hnRNP-F
(Fig. 3a). Of particular note, the punctate complexes of hnRNP-F and
NS1 were visualized in the cytoplasm adjacent to the perinuclear
membrane at 12 h post transfection (Fig. 3a), while co-localization of
hnRNP-F and NS1 was mainly detected in the nucleus at 24 h post
transfection (Fig. 3a). It is likely that the cytoplasmic co-localization
of these proteins at the earlier time point might be attributed to NS1
proteins that are not yet transported into the nucleus.
To further conﬁrm the co-localization of NS1 and endogenous
hnRNP-F, 293T cells were infected with inﬂuenza A/WSN/1933
CT
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Fig. 3. Co-localization of hnRNP-F with PR8-NS1. (a) Co-localization of hnRNP-F and PR8-NS1 in co-transfected cells. The localization patterns of hnRNP-F (Red) and NS1 (Green)
were determined at 12 and 24 h post co-transfection of cells with Flag-hnRNP-F andMyc-PR8-NS1 plasmids. Cytoplasmic punctate NS1–hnRNP-F complexes are indicated in the box.
(b) Co-localization of hnRNP-F andWSN-NS1 during inﬂuenza virus infection. The localization patterns of hnRNP-F (Red) and NS1 (Green) were determined at 6, 12, and 24 hpi with
inﬂuenza A/WSN/1933 (H1N1) virus at a multiplicity of infection (MOI) of 1. The combined images are shown in the Merged column. Scale bar: 10 μm.
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D(H1N1) at a multiplicity of infection (MOI) of 1. To complement
results obtained from transiently transfected cells above, live virus-
infected 293T cells were ﬁxed and incubated with anti-hnRNP-F
rabbit polyclonal and anti-NS1 monoclonal antibodies simultaneously
at 6, 12, and 24 h post infection (p.i.). As shown in Fig. 3b, virus
infection resulted in nuclear staining of hnRNP-F and NS1 as early as 6
h gradually increasing at later time points (12 and 24 h), indicative of
abundant nuclear co-localization of these proteins. In combination
with the immunoprecipitation shown in Figs. 1 and 2, these data
strongly suggest that the binding complexes composed of hnRNP-F
and NS1 are abundantly localized in the nucleus.
Mapping of the NS1 and hnRNP-F interacting domain
NS1 protein is divided into two distinct functional domains: an
N-terminal RNA-binding domain (amino acid residues 1–73) and a
C-terminal ‘effector’ domain (residues 74–230) (Kochs et al., 2007).
In addition, amino acid (aa) residues 226–230 of NS1 have been
recognized as a putative PDZ interaction domain (Kochs et al., 2007).
To identify the region of NS1 that interacts with hnRNP-F, GST-full
length hnRNP-F fusion protein was subjected to GST pull-down with
ﬁve NS1 fragments (Fig. 4a). We found that four NS1 fragments (PR8
NS1 full, PR8 NS1 1-73, PR8 NS1 1-186, and PR8 NS1 1-226) were
pulled down with GST-hnRNP-F. One NS1 fragment (PR8 NS1 Δ73)
which bears the RNA-binding domain deletion (1–73 aa residues)
was not pulled down (Fig. 4b).
hnRNP-F has three RNA-binding domains (RBDs) and one GY-rich
region, which is an auxiliary domain between RBD II and III (Yoshida
et al., 1999). To determine which region of hnRNP-F is required for
speciﬁc interaction with the NS1 protein, Flag-tagged full length
RE
TRhnRNP-F and various truncated mutants were subjected to GST pull-
down with the GST-full length PR8 NS1 fusion protein (Fig. 5a). We
found that only the fragment containing the GY-rich region of hnRNP-
F interacted with NS1 (Fig. 5b). Together, these results indicate that
the RBD of NS1 protein (aa residues 1–73) and the GY-rich region of
hnRNP-F are the critical binding regions between the two proteins.
Altered expression of cellular hnRNP-F inﬂuences inﬂuenza
virus replication
Severalmembers of the hnRNP family have been recently shown to
enhance virus replication (Gupta et al., 1998; Hwang et al., 2009; Lin et
al., 2009; Sikora et al., 2009), with a number of contrasting reports
(Bolinger and Boris-Lawrie, 2009; Jablonski and Caputi, 2009). In
inﬂuenza virus-infected cells, cellular mRNA expression levels of
hnRNP-F were decreased down to ∼5 times lower relative to control
(mock-infected cells) particularly at 24 h p.i. (Fig. 6a, left panel)
indicating that virus infection somehow alters the accumulation of
hnRNP-F. To test this hypothesis and assess the role of hnRNP-F in
regulating inﬂuenza virus replication, we depleted endogenous
hnRNP-F using small interference RNA (siRNA)-mediated knockdown
technology, or upregulated hnRNP-F in 293T cells by exogenous trans-
fection with Flag-hnRNP-F plasmid. At least three hnRNP-F-speciﬁc
siRNAs, targeting different regions of the hnRNP-F gene, were veriﬁed
for their efﬁciency to reduce cellular endogenous protein along with a
negative control siRNA, comprising sequence unrelated to any known
genes, in 293T cells. As shown in Fig. 6a (right panel), all three hnRNP-
F-speciﬁc siRNAs, except the control, were able to decrease hnRNP-F
expression levels but not the expression of β-actin ruling out off target
effect of the gene silencing. However, the most efﬁcient siRNA duplex
Fig. 4. Mapping of NS1 protein domain responsible for binding to hnRNP-F protein. (a) Schematic representation of diverse truncated NS1 constructs. The diverse truncated NS1
constructs tested for interaction with full-length hnRNP-F by GST pull-down assay. (b) GST pull-down assay with NS1. GST-hnRNP-F or GST alone was incubated with whole cell
extracts from293T cells expressing full-lengthMyc-PR8-NS1 and a series of truncatedMyc-PR8-NS1. The bound proteinswere analyzed byWestern blot using anti-c-Mycmonoclonal
antibody. The lower panel indicates the amount of GST and GST-hnRNP-F determined by Coomassie blue staining. ⁎, puriﬁed GST-hnRNP-F as major band. +, non-speciﬁc bacterial
protein which may have interacted with hnRNP-F or possibly degraded proteins during puriﬁcation.
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D(S2) was selected for testing in the foregoing experiments. Therefore,
293T cells were transfected with an empty vector (C1), control siRNA
(C2), hnRNP-F siRNA, or Flag-hnRNP-F plasmid then infected with
inﬂuenza A/WSN/1933 (H1N1) at an MOI 1 after 24 h. As expected,
endogenous expression of hnRNP-F mRNA and protein was markedly
decreased in the hnRNP-F-speciﬁc siRNA-transfected cells in a time-
dependent manner (Fig. 6b). To determine inﬂuenza virus replication
rates in the hnRNP-F-depleted and -overexpressing cells, virus-
infected cell culture media were harvested at 12, 24, and 36 hpi
followed by virus titration in 11-day-old embryonated chicken eggs.
Therewere no signiﬁcant differences in virus yield from culturemedia
grown with any of the treated cells at 12 h post infection (Fig. 6c).
However, virus titers from hnRNP-F siRNA-transfected samples were
10–100 times higher than titers from negative control siRNA-
transfected samples at 24 h and 36 hpi, respectively (pb0.05)
(Fig. 6c). In contrast to the siRNA treatments, there are no considerable
differences of viral titers in hnRNP-F-overexpressing cells at 24 and
36 hpi compared with empty vector-transfected cells (pN0.05)
(Fig. 6c). These results suggest that host cellular hnRNP-F protein
plays a suppressive role in inﬂuenza virus replication.
NS1–hnRNP-F complex leads to alterations of viral polymerase activity
and host gene expression
The viral ribonucleoproteins (vRNPs) are responsible for viral
transcription that takes place in the nucleus of infected cells (Herz
et al., 1981). Since hnRNPs are predominantly localized in the nucleus
RE
TR (Michael et al., 1995), it is plausible that hnRNP-F might inﬂuenceviral polymerase activity. We ﬁrst co-transfected inﬂuenza viral RNP,pHW72 M-Luc, and pCMV-β-gal (for standardization) into 293T cellsalong with the hnRNP-F-siRNA, hnRNP-F plasmid, NS1 plasmid, nega-tive control siRNA, or empty vector, and then conducted a luciferasereporter gene assay to determine viral polymerase activity. As shownin Fig. 6d, both the empty vector and control siRNA had no effect on
viral polymerase activity. The highest polymerase activity was
observed in hnRNP-F siRNA-treated cells at all time points (12, 24,
and 36 h post transfection), which is consistent to increased virus
titers in inﬂuenza-infected cells (Fig. 6c). In contrast, polymerase
activity was not affected at any time point tested in this study
(3 different replicates) when hnRNP-F over expression was used in
the polymerase assay. High luciferase activity was also noted in NS1-
transfected cells at all time points. The inﬂuenza NS1 viral protein is a
well-known multifunctional protein with plethora of activities all of
which could contribute toward efﬁcient virus replication and viru-
lence during infection. Collectively, these data relatively indicate that
hnRNP-F may have a regulatory effect on inﬂuenza virus replication
but the inﬂuenza virus NS1 could modulate its activity.
Since hnRNP complexes play a crucial role in gene expression by
controlling maturation of primary mRNA transcripts (Dreyfuss et al.,
1993), and NS1 leads to alteration of host gene transcription and
expression by suppressing cellular mRNA processes (Hale et al.,
2008b), it is possible that binding of NS1 to cellular hnRNP-F could
induce inﬂuenza virus replication by altering host gene expression
leading to enhanced viral replication. To address this hypothesis, we
Fig. 5.Mapping of the hnRNP-F protein domain responsible for binding to the PR8-NS1 protein. (a) Schematic representation of diverse truncated hnRNP-F constructs. The diverse truncated hnRNP-F constructs were tested for interaction
with full-length PR8-NS1 by GST pull-down assay. (b) GST pull-down assay with hnRNP-F. GST-PR8-NS1 or GST alone was incubated with whole cell extracts from 293T cells expressing full-length Flag-hnRNP-F and a series of truncated
Flag-hnRNP-F. The bound proteins were analyzed by Western blot using an anti-Flag monoclonal antibody. The lower panel indicates the amount of GST and GST-PR8-NS1 determined by Coomassie staining.
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Aperformed luciferase assays to determine the transcriptional activity
of the anti-viral gene interferon β (IFN-β) in the cells co-transfected
with hnRNP-F-siRNA, hnRNP-F plasmid, NS1 plasmid, or control
empty vector, along with an IFN-β promoter-luciferase reporter gene
plasmid, and pCMV-β-gal (for standardization). As shown in Fig. 6e,
the transcriptional activity of the IFN-β promoter slightly declined
upon NS1 overexpression and hnRNP-F depletion notably at 24 h post
transfection relative to empty vector and control siRNA (pb0.05 for
both treatments), respectively. As a major function, NS1 antagonizes
IFN-α or -β-mediated antiviral responses (Hale et al., 2008b) as was
also demonstrated in this assay. Surprisingly, although viral polymer-
ase activity and virus growth were not affected by exogenous
upregulation of hnRNP-F (Figs. 6c and d), the promoter activity was
robustly elevated in cells overexpressing the hnRNP-F protein. Taken
altogether, it is plausible that hnRNP-F protein is normally involved in
cellular transcription and/or gene expression, but the function is
suppressed by interactionwith NS1 during inﬂuenza virus infection to
favor propagation.
Discussion
It has been well-documented that virus infection gives rise to
numerous interactions between viral gene products and host cellular
factors, and these interactions play crucial roles in virus propagation,
host susceptibility to infection, and disease progression. NS1 is one of
the non-structural genes of the inﬂuenza A virus, and encodes a
protein of 234–237 amino acids (depending on the virus strain) that
localizes in the nucleus without the existence of other viral proteins
(Kawaoka et al., 1998). NS1 contains two functional domains; the
RNA-binding domain and the effector domain (Murayama et al.,
2007) that act as a regulatory factor during infection (Krug et al.,
2003; Kash et al., 2006; Hale et al., 2008a). For instance, the RNA-
binding domain of NS1 regulates viral mRNA translation and cellular
mRNA processes by interacting with numerous host cellular proteins
(Li et al., 2006; Murayama et al., 2007; Yin et al., 2007). Therefore,
interaction of NS1 with host cellular proteins should be a critical
determinant for virus propagation in host cells by either stimulating
viral replication or suppressing the host cell defense system. To gain a
precise insight into how NS1 regulates virus survival and host cell
defense mechanisms, we initially performed a yeast two-hybrid
screen analysis to identify novel NS1-interacting cellular proteins
(data not shown). In the present study, we validated the speciﬁc
binding kinetics of NS1 and hnRNP-F, and their biological signiﬁcance
in virus propagation and cellular gene expression. Since NS1
sequences vary according to virus strain (Petri et al., 1982), cellular
interacting factors for NS1 and their biological functions are also
signiﬁcantly different among strains (Kochs et al., 2007). We found
that interactions between NS1 and hnRNP-F might be relatively well-
conserved in different inﬂuenza virus strains (i.e., avian and human)
because hnRNP-F enabled interaction with different strain-derived
NS1 proteins despite marked differences in amino acid sequences. In
addition, we also found that NS1 and hnRNP-F, both of which are
known RNA-binding proteins, are able to interact with each other in
the absence of RNA.
Consistent with previous reports showing that hnRNP-F is mainly
detected throughout the nucleoplasm in HeLa cells as shown by low
levels of punctuate cytoplasmic immunoﬂuorescence (Matunis et al.,
1994), and that inﬂuenza virus NS1 can be found in both the nucleus
and the cytoplasm (Li et al., 1998; Wolff et al., 1998), our study
showed that NS1 co-localizes with endogenous and exogenous
hnRNP-F proteins mainly in the nucleus of virus-infected cells, and
hnRNP-F/NS1 transiently transfected cells, respectively. At the earlier
phase of infection, punctate cytoplasmic NS1- hnRNP-F complexes
could be observed (Fig. 3). However, as the infection progresses,
interaction appears to be concentrated in the nucleus suggesting
initial interaction occurring at the cytoplasmic level.
ET
RWe also demonstrated that the NS1–hnRNP-F complex forms by
binding interactions between the glycine–tyrosine (GY)-rich region of
human hnRNP-F and the RNA-binding region (aa residues 1–73) of
NS1. The GY-rich region of hnRNP-F includes a number of short
repeated peptides, including six Tyr-Ser dipeptides and four Gly-X-
Tyr-(Asp/Glu) peptides (Matunis et al., 1994). Although the biological
signiﬁcance of these peptide repeats is as yet unknown, the
distribution of glycine, serine, and tyrosine is common in the auxiliary
domains of hnRNP A and hnRNP B, which are proposed to be impor-
tant for protein–protein interactions (Burd et al., 1989; Matunis et al.,
1994). Therefore, interaction of NS1 and cellular hnRNP-F may be a
speciﬁc example of a general phenomenon, and plays a crucial role in
controlling physiological homeostasis between host and virus.
Although a number of studies have suggested that various hnRNP
proteins are involved in cellular processes related to virus replication
and translation (Gupta et al., 1998; Noisakran et al., 2008; Paek et al.,
2008; Hwang et al., 2009; Lin et al., 2009; Sikora et al., 2009), the
abundantly expressed hnRNPs (A1, A2, and E1) are shown to
negatively regulate virus propagation and translation of the human
immunodeﬁciency virus type 1 (Bolinger and Boris-Lawrie, 2009;
Jablonski and Caputi, 2009). In the current study, our results show that
depletion of hnRNP-F by siRNA enhanced virus propagation by 10- to
100-fold (Fig. 6c) and efﬁciently induced high viral polymerase
activity, similar to NS1 overexpression (Fig. 6d). Intriguingly though,
overexpression of hnRNP-F increases transcriptional activity of IFN-β,
a major anti-viral factor, despite no apparent effect both on virus
replication and polymerase activity (Figs. 6c and d). At present, we do
not know themolecularmechanismunderlying this seemingly contra-
dictory result. We could only hypothesize that hnRNP-F is involved in
host cellular processes as suggested in literature, probably including
but not limited to expression of immune response-related elements
(i.e. IFN-β induction), suggesting that hnRNP-F could be a host anti-
viral or restricting factor. However, since NS1 suppresses IFN pro-
duction at both pre-transcriptional and post-transcriptional levels
(Hale et al., 2008b), it is plausible thatNS1might regulate a viral defense
system that hinders proper cellular gene expression via inhibition of
hnRNP-F-mediated mRNA expression resulting otherwise into en-
hanced viral polymerase activity and virus propagation. Alternatively,
hnRNP-F might be part of a more complex process of host cellular
activities involving other members of the hnRNP family targeted by
inﬂuenza viral proteins, not only NS1, during infection aimed at
enhancing replication. Indeed, Jorba et al (2008) have identiﬁed
hnRNP-M and hnRNP-H1 proteins as binding partners of the inﬂuenza
virus polymerase complex. Therefore, more detailed studies are needed
to clearly elucidate the mechanisms that govern the interplay of host
cellular and viral proteins. Nevertheless, our results provide new
insights into how the inﬂuenza virus NS1 protein accelerates virus
replication through direct interaction with cellular hnRNP-F protein.
Materials and methods
Cell culture and viruses
Human embryonic kidney (HEK) 293T cells were cultured in
Dulbecco's modiﬁed Eagle's medium (DMEM, GIBCO-BRL) supplemen-
tedwith antibiotics (penicillin, 100 U/ml, streptomycin, 10 μg/ml) and
10% fetal bovine serum (FBS, GIBCO-BRL) at 37 °C and suppliedwith 5%
CO2. A/PuertoRico/8/1934 (H1N1), A/WSN/1933 (H1N1), andA/EM/
Korea/W150/2006 (H5N1) were propagated at 37 °C in 11-day-old
embryonated chicken eggs. Virus titerswere determined inMDCK cells
by TCID50 assay.
Plasmid DNA constructs
For the generation of Myc-tagged NS1 expression plasmids,
three NS1 genes from A/Puerto Rico/8/1934 (H1N1) (Myc-PR8-
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ANS1), A/WSN/1933 (H1N1) (Myc-WSN-NS1), and A/EM/Korea/
W150/2006 (H5N1) (Myc-W150-NS1) were ampliﬁed from cDNA
templates that were synthesized from RNA extracts of respective
viruses. Myc-tagged NP (Myc-PR8-NP) expression plasmid was also
generated similarly using NP gene from A/Puerto Rico/8/1934
(H1N1) as template. The amplicons were digested with EcoRI and
KpnI, and then inserted into the pcDNA3.1-Myc-His plasmid vector
(Invitrogen). To construct the plasmid Flag-hnRNP-F, the hnRNP-F
(GenBank accession number NM_001098206) cDNA from 293T cells
was ampliﬁed by RT-PCR using hnRNP-F-speciﬁc primer sets, and
then PCR products were cloned into the pFLAG-CMV (Sigma)
plasmid vector using BglII and XbaI enzyme sites. GST-hRNP-F and
GST-PR8 NS1 plasmids were constructed to perform glutathione S-
transferase (GST) pull-down experiments. hnRNP-F and NS1 were
ampliﬁed using the Flag-hnRNP-F and Myc-PR8 NS1 vectors,
respectively, with a set of primers corresponding to the 5′- and 3′-
ends of the hnRNP-F and NS1 coding region, and then cloned into
the pGEX-5X plasmid vector at BglII and XhoI sites (GE Healthcare).
NS1 deletion mutants were constructed to determine the inter-
action sites to hnRNP-F. Truncated NS1 series were ampliﬁed from the
Myc-PR8 NS1 vector, and were inserted into the EcoRI and KpnI sites
of the pcDNA3.1-Myc-His-tagging plasmid. hnRNP-F truncated
mutants were constructed to identify its interaction site to NS1. The
truncated hnRNP-F series were cloned into the BglII and XbaI enzyme
sites of the pFLAG-CMV vector (schematic representation of the
diverse NS1 and hnRNP-F truncations used for the GST pull-down
assays are shown in Figs. 4a and 5a).
All constructed plasmids were conﬁrmed by DNA sequencing, and
the primer sets used for these plasmid constructions are available
upon request.
Antibodies
The following antibodies were used: Anti-Flag (M2) monoclonal
antibody (Sigma), anti-c-Myc (9E10)monoclonal antibody (Covance),
anti-hnRNP-F rabbit polyclonal antibody (Abcam), anti-NS1 mono-
clonal antibody (Santa Cruz), mouse IgG (Sigma), andHRP-conjugated
anti-mouse IgG and anti-rabbit IgG (Jackson Immunoresearch). The
following ﬂuorescent secondary antibodies were used: Alexa Fluor
488-conjugated anti-mouse IgG and Alexa Fluor 594-conjugated anti-
rabbit IgG (Invitrogen).
Transfection
293T cells were cultured in a 10-cm culture dish (Nunc) at a
density of 5×106 cells/dish. A total of 15 μg of various plasmids was
transfected by a standard CaPO4 precipitation assay, according to a
previously described protocol (Jackel-Cram et al., 2007). At 30 h post
transfection, cell lysates were prepared and subjected to GST pull-
down and immunoprecpitation assays.ET
R
Fig. 6. NS1–hnRNP-F complex leads to alterations of inﬂuenza virus replication and cellular
Cells were transfected with hnRNP-F-speciﬁc siRNA and harvested at different time points (2
were analyzed by real time RT-PCR and Western blotting (using anti-hnRNP-F rabbit polycl
used as controls for real time RT-PCR and Western blot assays, respectively. (c) Altered cell
-overexpressing 293T cells were infected with inﬂuenza A/WSN/1933/H1N1 at anMOI 1 afte
at different time points (12, 24, and 36 h post infection) by titration in 11-day-old embryon
titers (SD) from three independent titrations [⁎pb0.05, compare relative virus titers of ne
(Student's t-test)]. (d) Viral polymerase activity assay. Cells were co-transfected with the inﬂ
with hnRNP-F-siRNA, Flag-hnRNP-F, Myc-PR8-NS1, or empty vector. Cells were harvested at
of luciferase and β-Gal activity. Errors bars are mean±SD of at least three independent assay
activity of empty vector only against NS1 overexpression and of control siRNA only against h
transcriptional activity assay. Cells were co-transfected with interferon-β (IFN-β) promote
hnRNP-F-siRNA, Flag-hnRNP-F, Myc-PR8-NS1, or empty vector. Cells were harvested at dif
luciferase and β-Gal activities. Errors bars are mean±SD of at least three independent assay
activity of empty vector only against NS1 overexpression and hnRNP-F overexpression o
(Student's t-test)]. The expression levels of hnRNP-F and NS1 proteins were analyzed byWes
antibody, respectively. β-actin was used as a loading control for Western blot.Immunoprecipitation assay
293T cells were harvested at 30 h post transfection, washed three
times in phosphate-buffered saline (PBS), and then lysed in lysis buffer
(20 mM Tris–HCl, pH 7.4; 150 mMNaCl; 1 mM EDTA; 0.5% NP-40, and
1× complete protease inhibitor cocktail). Cell lysates were pre-cleared
by incubationwith protein-G beads (GEHealthcare) at 4 °C for 1 h, and
then pre-cleared supernatants were immunoprecipitated with 1 μg of
antibodies against c-Myc or Flag epitope along with protein-G beads.
The immunoprecipitates were washed with lysis buffer, denatured in
sodium dodecyl sulfate (SDS) loading buffer, and then analyzed by
Western blot. Brieﬂy, denatured immunoprecipitates were fraction-
ated by 10% SDS PAGE and transferred to PVDF membranes by semi-
dry immunoblot. Membranes were blocked with PBS containing 3%
bovine serum albumin (BSA, Sigma) for 1 h, incubated with anti-Flag
and/or anti-c-Myc monoclonal antibodies for 1 h (1: 4000), washed
three times with PBS containing 0.2% Tween 20, and then incubated
with secondary antibody (goat anti-mouse horseradish peroxidase-
conjugated antibody, 1:5000) for 1 h at room temperature. The
washed immunoblots were visualized with an enhanced chemilumi-
nescence reagent (ECL Advance Western Blotting Detection Kit; GE
Healthcare) using a LAS 3000 mini (FUJIFILM).
In vitro binding assay
Myc-tagged NS1 was expressed in 293T cells, as described above.
Cell lysates were harvested at 30 h post transfection and Myc-tagged
NS1 proteins were pulled down and immobilized using anti-Flag M2
agarose beads (Sigma). The beads were washed extensively in lysis
buffer. After a washing step, 15 μg of puriﬁed GST-tagged hnRNP-F
protein was added to the beads, and the mixtures were incubated at
4 °C overnight. The beads were washed three times and then boiled.
Proteins were detected by Western blotting with anti-Flag (1:5000).
GST pull-down experiments
GST-hnRNP-F, GST-PR8 NS1, and GST proteins were produced
from E. coli BL21 cells that were transformed with GST-hnRNP-F, GST-
PR8 NS1, or pGEX-5X empty plasmids, respectively. Cells were
induced with 0.1 mM IPTG (isopropyl-β-D-thiogalactopyranoside) at
22 °C overnight. The bacterial pellets were resuspended in PBS and
then sonicated to lyse the cells. Triton X-100 was added to the lysates
at a ﬁnal concentration of 1%, and the mixture was incubated for
30 min to aid in solubilization of the fusion protein. Pellets were
removed by centrifugation at 12,000×g for 10 min at 4 °C. The protein
concentration was measured by the Bradford assay. Aliquots of the
supernatant were stored at −80 °C until used. Aliquots of 15 μg GST
alone or GST-hnRNP-F or GST-PR8 NS1 fusion protein lysate was
bound to 25 μl of 50% pre-equilibrated glutathione–agarose bead
slurry (GE Healthcare) for 1 h at 4 °C. The beads were then washed
C
Egene expression. (a, b) Depletion of cellular hnRNP-F by siRNA-mediated knockdown.
4, 48, and 72 h post transfection). The mRNA and protein expression levels of hnRNP-F
onal antibody), respectively. The house-keeping gene GAPDH and β-actin protein were
ular level of hnRNP-F inﬂuences inﬂuenza virus replication. The hnRNP-F-depleted and
r 24 h post transfection. Virus titers in infected cell culture supernatants weremeasured
ated chicken eggs expressed as log10 EID50/100ul. Data are mean±standard deviation
gative control siRNA only against hnRNP-F depletion by siRNA-mediated knock-down
uenza virus RNP, pHW72-M-Luc, and pCMV-β-gal (for standardization) plasmids along
different time points (12, 24, and 36 h post transfection) and then subjected to analysis
s (prepared in triplicates) measured individually [⁎pb0.05, compare relative luciferase
nRNP-F depletion by siRNA-mediated knock-down (Student's t-test)]. (e) Cellular gene
r-luciferase reporter gene plasmid and pCMV-β-gal (for standardization) along with
ferent time points (12 and 24 h post transfection) and then subjected to analysis for
s (prepared in triplicates) measured individually [⁎pb0.05, compare relative luciferase
r of control siRNA only against hnRNP-F depletion by siRNA-mediated knock-down
tern blot using anti-hnRNP-F rabbit polyclonal antibody and an anti-c-Myc monoclonal
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Athree times with immunoprecipitation assay buffer (0.5 M Tris, pH
8.0; 0.15MNaCl; 0.1% SDS; 1% NP-40; 1% deoxycholate) containing 1×
complete protease inhibitor cocktail (Roche). Then, 500 μl of the
lysates (1 μg/μl) containing NS1, NS1 truncated proteins, hnRNP-F,
and hnRNP truncated proteins from 293T cells was incubated with
glutathione–agarose bead GST or glutathione–agarose bead GST
fusion protein complexes in PBS. After 6 h of incubation at 4 °C, the
beads were washed ﬁve times in immunoprecipitation assay buffer.
Bound proteins were resolved by SDS-PAGE, followed byWestern blot
with anti-c-Myc or anti-Flag monoclonal antibodies.
Real time RT-PCR
RNA from virus-infected cells was isolated using an Absolutely
RNA Mini Prep kit (Stratagene) according to the manufacturer's
protocol, and reverse-transcribed using 5X i-Script Reaction Mix
(containing oligo dT and random hexamers) and i-Script reverse
transcriptase (Bio-Rad). The quantitative transcription proﬁle of
hnRNP-F and NS1 was determined by real time RT-PCR using primer
sets speciﬁc for hnRNP-F (hnRNP-F sense: 5′-acagaaccgagatggattgg-
3′ and hnRNP-F antisense: 5′-taactcctgcgaggcaaact-3′) and NS1 (NS1
sense: 5′-agcaaaagcagggtgacaa-3′ and NS1 antisense: 5′-
ttctgatctccggcgcagccg-3′). Relative concentration values were nor-
malized to expression levels of GAPDH. RNA quantiﬁcation was
conducted at least three times using the SYBR green PCR master mix
(Qiagen) kit as per the manufacturer's instructions in a Corbett Rotor-
Gene RG-3000 (Corbett Life Science) under identical ampliﬁcation
conditions. Fold change of hnRNP-F expression was evaluated using
the Delta–Delta Ct method (Yuan et al., 2008). The threshold cycle is
deﬁned as the cycle number where ﬂuorescent signaling crosses the
threshold of logarithmic increases in cDNA concentration.
siRNAs
Duplex small interfering RNAs (siRNAs) targeting hnRNP-F
[hnRNP-F siRNAs: S1 (5`-GGUGUCCAUUUCAUCUACAtt-3`); S2 (5′-
UCAGUGUUUUCUCAUGCA AdTdT-3′); and S3 (5`-AAUGAGUAAA-
CUAAAACUAUU-3`)] and a validated negative control siRNA (5`-
CCUACGCCAAUUUCGU-3`) with limited sequence identity to known
genes were purchased from Bioneer Inc. (Taejon, Korea). 293T cells
were grown in six-well plates (Nunc) at 70% conﬂuency and were
transfected with the siRNA complexes (250 pmol per well) using
Lipofectamine 2000 (Invitrogen) as recommended by the manufac-
turer. Cells were harvested at designated time points post transfection
and assayed for activity by Western blot and real time RT-PCR.
Double immunoﬂuorescence staining
Flag-hnRNP-F and Myc-PR8 NS1 vectors were co-transfected into
293T cells grown on 35-mm glass bottom culture dishes (Nunc). At
various time points, cells were ﬁxed with 4% formaldehyde in PBS for
15 min, and treated with absolute methanol for 10 min at room
temperature. Cells were permeabilizedwith PBS-T (PBS-0.2% Triton X-
100) for 10min at room temperature, and then blockedwith 2% BSA in
PBS for 2 h at room temperature. Thereafter, the cells were incubated
for 6 h at 4 °C with anti-c-Myc and anti-hnRNP-F primary antibodies,
followed by incubation with Alexa Fluor 488-conjugated secondary
anti-mouse IgG and Alexa Fluor 594-conjugated secondary anti-rabbit
IgG antibodies for 2 h at room temperature in the dark. Cells were then
washed three timeswith PBS between incubations and analyzed using
a TCS SP2 Leica laser scanning confocal microscope (Leica).
Luciferase reporter assay
Viral polymerase activities were measured by luciferase activity
assay as described previously (Salomon et al., 2006). The open reading
RE
TRframe of the enhanced green ﬂuorescent protein (EGFP) in the
pHW72M-EGFP plasmid (kindly provided by Robert Webster, St. Jude
Children's Research Hospital) was replaced with the luciferase gene
(pHW72M-Luc). Polymerase set (0.3 μg of pHW72M-Luc, pHW2000-
PB2, pHW2000-PB1, pHW2000-PA, pHW2000-NP, and pCMV-β-gal)
and target genes (0.3 μg of pFlag-CMV empty vector, Flag-hnRNP-F,
Myc-PR8 NS1 vector, 100 pmol siRNA against hnRNP-F) or a validated
negative control siRNA was transfected into 293T cells using TransIT-
LT1 (Mirus) according to the manufacturer's instructions. The cellular
activity of hnRNP-F was also measured by a luciferase activity assay.
Cellular activity set (0.3 μg of plasmid (pGL3:IFN-β and pCMV:β-
galactosidase) and target genes (0.3 μg of pFlag-CMV empty vector,
Flag-hnRNP-F, Myc-PR8 NS1 vector, or 100 pmol siRNA against
hnRNP-F) were co-transfected into 293T cells using TransIT-LT1.
Transfection media were removed after 6 h post transfection and
replaced with fresh media. The cells were harvested at the designated
time points (12, 24, and 36 h), washed with PBS, and then lysed with
100 μl lysis buffer (Promega). Thereafter, luciferase and β-gal acti-
vities were analyzed using the Luciferase Assay system (Promega) and
an ONPG (o-nitrophenyl-β-D-galactopyranoside)-based β-Gal assay,
respectively. Data are presented as means±standard deviation (SD)
from measurements of three independent assays (prepared in
triplicates) and p value was calculated using the Student's t-test. A
value of pb0.05 value was considered statistically signiﬁcant.
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